These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions. Jiang ZY; Lu MC; You QD J Med Chem; 2016 Dec; 59(24):10837-10858. PubMed ID: 27690435 [TBL] [Abstract][Full Text] [Related]
3. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction. Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486 [TBL] [Abstract][Full Text] [Related]
4. A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity. Tran KT; Pallesen JS; Solbak SMØ; Narayanan D; Baig A; Zang J; Aguayo-Orozco A; Carmona RMC; Garcia AD; Bach A J Med Chem; 2019 Sep; 62(17):8028-8052. PubMed ID: 31411465 [TBL] [Abstract][Full Text] [Related]
5. Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases. Pallesen JS; Tran KT; Bach A J Med Chem; 2018 Sep; 61(18):8088-8103. PubMed ID: 29750408 [TBL] [Abstract][Full Text] [Related]
6. The Keap1-Nrf2 protein-protein interaction: A suitable target for small molecules. Schmoll D; Engel CK; Glombik H Drug Discov Today Technol; 2017 Jun; 24():11-17. PubMed ID: 29233294 [TBL] [Abstract][Full Text] [Related]
7. Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability. Lazzara PR; David BP; Ankireddy A; Richardson BG; Dye K; Ratia KM; Reddy SP; Moore TW J Med Chem; 2020 Jun; 63(12):6547-6560. PubMed ID: 31682434 [TBL] [Abstract][Full Text] [Related]
8. Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction. Abed DA; Lee S; Hu L Bioorg Med Chem; 2020 Mar; 28(6):115343. PubMed ID: 32046917 [TBL] [Abstract][Full Text] [Related]
9. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides. Lu MC; Yuan ZW; Jiang YL; Chen ZY; You QD; Jiang ZY Mol Biosyst; 2016 Apr; 12(4):1378-87. PubMed ID: 26935067 [TBL] [Abstract][Full Text] [Related]
10. Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction. Wells G Biochem Soc Trans; 2015 Aug; 43(4):674-9. PubMed ID: 26551711 [TBL] [Abstract][Full Text] [Related]
11. Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds. Pallesen JS; Narayanan D; Tran KT; Solbak SMØ; Marseglia G; Sørensen LME; Høj LJ; Munafò F; Carmona RMC; Garcia AD; Desu HL; Brambilla R; Johansen TN; Popowicz GM; Sattler M; Gajhede M; Bach A J Med Chem; 2021 Apr; 64(8):4623-4661. PubMed ID: 33818106 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1). Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency. Lu MC; Jiao Q; Liu T; Tan SJ; Zhou HS; You QD; Jiang ZY Eur J Med Chem; 2018 Jan; 143():1578-1589. PubMed ID: 29117896 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism. Horie Y; Suzuki T; Inoue J; Iso T; Wells G; Moore TW; Mizushima T; Dinkova-Kostova AT; Kasai T; Kamei T; Koshiba S; Yamamoto M Commun Biol; 2021 May; 4(1):576. PubMed ID: 33990683 [TBL] [Abstract][Full Text] [Related]
15. Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction. Lee S; Abed DA; Beamer LJ; Hu L SLAS Discov; 2021 Jan; 26(1):100-112. PubMed ID: 32564647 [TBL] [Abstract][Full Text] [Related]
16. Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction. Steel RJ; O'Connell MA; Searcey M Bioorg Med Chem Lett; 2018 Sep; 28(16):2728-2731. PubMed ID: 29534931 [TBL] [Abstract][Full Text] [Related]
17. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670 [TBL] [Abstract][Full Text] [Related]
18. Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2). Zhong M; Lynch A; Muellers SN; Jehle S; Luo L; Hall DR; Iwase R; Carolan JP; Egbert M; Wakefield A; Streu K; Harvey CM; Ortet PC; Kozakov D; Vajda S; Allen KN; Whitty A Biochemistry; 2020 Feb; 59(4):563-581. PubMed ID: 31851823 [TBL] [Abstract][Full Text] [Related]
19. Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors. Richardson BG; Jain AD; Potteti HR; Lazzara PR; David BP; Tamatam CR; Choma E; Skowron K; Dye K; Siddiqui Z; Wang YT; Krunic A; Reddy SP; Moore TW J Med Chem; 2018 Sep; 61(17):8029-8047. PubMed ID: 30122040 [TBL] [Abstract][Full Text] [Related]
20. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update. Lu MC; Ji JA; Jiang ZY; You QD Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]